NeoGenomics, Inc. (NEO)
16.65
-0.60
(-3.48%)
USD |
NASDAQ |
Oct 16, 16:00
16.50
-0.15
(-0.90%)
After-Hours: 20:00
NeoGenomics Research and Development Expense (Annual) : 37.08M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 37.08M |
| December 31, 2024 | 31.16M |
| December 31, 2023 | 27.31M |
| December 31, 2022 | 30.33M |
| December 31, 2021 | 21.87M |
| December 31, 2020 | 8.029M |
| December 31, 2019 | 8.387M |
| December 31, 2018 | 3.001M |
| December 31, 2017 | 3.636M |
| December 31, 2016 | 4.649M |
| December 31, 2015 | 3.97M |
| December 31, 2014 | 2.394M |
| Date | Value |
|---|---|
| December 31, 2013 | 2.217M |
| December 31, 2012 | 2.099M |
| December 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| December 31, 2002 | 0.0464M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median